Robert F. Miller

Robert Miller advises a wide variety of health care companies on corporate and regulatory issues. Recognized for his creative problem-solving and unusually broad-based experience in both business and health law, Robert advocates for clients that include health systems, hospitals, technology companies, physician groups, management organizations, and investors in health care businesses. Clients turn to him when they’re looking to gain solid commercial outcomes and drive their business goals forward through legal processes.

Robert draws on his keen insight into transactions within the heavily regulated health care industry to counsel large, sophisticated organizations grappling with multifaceted problems that can’t be resolved with off-the-shelf solutions. He works alongside clients to develop strategies that fit within the health care regulatory framework. 

A seasoned negotiator, Robert represents clients in mergers and acquisitions, including the purchase, sale, or leasing of health care facilities such as hospitals, skilled nursing facilities, ambulatory surgery centers, and pharmacies. He also guides clients through complex physician group and health system affiliations using joint venture and contractual models that present alternatives to straight sales or acquisitions and offer a broad spectrum of creative governance and ownership arrangements.

Health care provider clients depend on Robert to counsel them on business entity structure and formation, technology transactions, capital generation through private offerings and syndications, and other general corporate concerns.

Robert is also a trusted advisor on health care antitrust and competition issues, helping providers navigate the challenges posed by increasing regulatory scrutiny of transactions, affiliations, and network development initiatives. He routinely counsels hospitals, health systems, skilled nursing facilities, physician groups, and other health care organizations on antitrust considerations related to mergers and acquisitions, joint ventures, clinically integrated networks, and other collaborative arrangements. Combining sophisticated transactional experience with a deep understanding of health care regulation, he helps clients pursue strategic growth opportunities while managing competitive risk and maintaining compliance with federal and state antitrust laws. He is frequently sought out for his insights on emerging antitrust enforcement trends impacting the health care industry.

Robert also advises provider clients on fraud and abuse issues in the context of both transactions and regulatory compliance, including internal investigations, analyses of reporting requirements, and related disclosures to governmental agencies. He routinely directs companies on contractual matters, including the development of agreements regarding software licensing, distribution, non-disclosure, professional services, and consulting.

He understands his clients’ business needs and assists in devising ways to meet them. Robert consults with clients who are motivated to improve both health care delivery and their bottom lines. He walks them through potential growth strategies, innovative approaches to value-based care, and advanced data-use technology, all with a focus on achieving their individual objectives.

Robert works to get his clients thinking and talking about what strategic outcomes they would like to see, why those outcomes are important, and how to achieve them. He then presents clients with a range of options to designed to meet their goals. By asking the right questions and helping his clients think through the implications of their answers, he delivers results that are grounded in providing high-quality legal services, but often go much, much further. 

Representative Experience

Mergers and Acquisitions

• Represented independent physician practice group including dozens of providers in its sale to a nationally recognized medical services company.
• Represented multi-office regional optometry practice in its sale to a private equity backed strategic buyer. 
• Represented lab equipment and medical device distributor in its sale to a Fortune 50 pharmaceutical and medical supplies distribution company.
• Represented independent hospital in the sale of its long-term care unit to a private equity-backed senior living provider.
• Represented independent hospital in its sale to a publicly traded hospital company.
• Represented regional healthcare system in its acquisition of an independent hospital.
• Represented multinational manufacturing company in its sale to a European-based strategic buyer.
• Represented regional healthcare system in its acquisition of 11 physician practices within approximately the past two years.
• Represented global electronics company in its acquisition of a video surveillance software provider.
• Represented pharmaceutical development and manufacturing company in its sale to an Indian-based global business conglomerate.
• Represented biopharmaceutical manufacturing company in its sale to a strategic buyer. 
• Represented global consumer products company in its development of a joint venture with an Israeli-based, multinational aesthetic device company.
• Represented community-based health plan in its sale to a managed health care company.

Antitrust and Competition

• Represented post-acute care joint venture in its formation and development of a statewide network model.
• Represented national organization in the development, implementation, and operation of multiple statewide clinically integrated networks.
• Represented statewide network in the design, development, and implementation of a value-based care model across the continuum of care.
• Represented large academic medical center in the development of a service line joint venture model.

Corporate Finance

• Represented consortium of grocery stores and markets in renegotiating a $300M revolving line of credit.
• Represented consortium of insurance entities in renegotiating a $12M term loan and $2M revolving line of credit.
• Represented private equity backed hospital company in the renegotiation of a $55M revolving line of credit.

Capital Markets

• Represented regional healthcare system in the issuance of $68M in Series A bonds and $25M in Series B bonds.
• Represented food safety technology company in a $17M growth-stage equity offering.  
• Represented consumer products company in multiple rounds of early- and growth-stage equity offerings.
• Represented real estate investment company in a series of early-stage equity offerings.